UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER
Clinical trials for UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach aims to control inoperable rectal cancer recurrence
Disease control Recruiting nowThis phase II trial is testing whether a high-precision radiation technique called stereotactic body radiation therapy (SBRT) can help control locally recurrent rectal cancer that cannot be surgically removed. The study will enroll 40 adults aged 18-75 with unresectable tumors an…
Matched conditions: UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy offers hope for hard-to-treat rectal cancer
Disease control Recruiting nowThis study tests whether combining targeted radiation (SBRT) with an immunotherapy drug (PD-1 antibody) can help people whose rectal cancer has returned and cannot be surgically removed. About 31 adults with a specific type of colorectal cancer will receive the treatment and be f…
Matched conditions: UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC